FDA extends expiration date for swath of Mylan’s Epipens amid shortage

In an attempt to mitigate an ongoing shortage of Epipen auto-injectors, the FDA today extended the expiration date of specific lots of 0.3-mg devices by four months.

The move to extend the expiration dates beyond the approved 20-month shelf-life is based on stability data provided by Mylan (NSDQ:MYL) to the FDA, the U.S. regulatory agency reported.

Get the full story at our sister site, Drug Delivery Business News.

The post FDA extends expiration date for swath of Mylan’s Epipens amid shortage appeared first on MassDevice.

from MassDevice https://ift.tt/2BDfN3I